每经AI快讯，顺博合金（SZ 002996，收盘价：7.31元）发布公告称，2025年12月19日上午 10:00~11:00，顺博合金接受凯丰投资等投资者调研，公司董事会秘书李晓华参与接待，并回答了投资 者提出的问题。 （记者 曾健辉） 截至发稿，顺博合金市值为49亿元。 每经头条（nbdtoutiao）——海南封关首日直击：为中国探路，全球最大自贸港如何重塑开放边界？ 2025年1至6月份，顺博合金的营业收入构成为：废弃资源综合利用业占比98.89%，其他业务占比 1.11%。 ...

Group 1: Financial Performance - In the first nine months of 2025, the company achieved operating revenue of 1,126,602.78 million yuan, representing a year-on-year growth of 13.88% [1] - The net profit attributable to shareholders of the listed company was 24,503.93 million yuan, with a year-on-year increase of 49.12% [1] Group 2: Production Capacity and Utilization - The first phase of the Anhui project has a production capacity of 400,000 tons of cast aluminum alloy, with a cumulative capacity utilization rate of 86.54% as of the end of Q3 2025 [2] Group 3: Pricing Strategy - The company employs two pricing models: 1. Market-based pricing, which allows for better control of raw material price fluctuations due to strong correlations with market prices of aluminum materials [3] 2. Cost-plus pricing, which locks in raw material price risks to ensure reasonable profit margins [3] Group 4: Market Applications - The company's products are primarily used in various industries, with the automotive sector accounting for approximately 53%, motorcycles for about 5%, telecommunications for around 5%, and machinery for about 11% [4] Group 5: Future Projects and Applications - The Anhui Phase II project will focus on aluminum plate and strip products, targeting applications in battery foils, battery housings, beverage cans, 3C product materials, and aluminum for tankers, aligning with trends in green packaging and new energy vehicles [5] Group 6: Convertible Bonds Consideration - The company will consider its convertible bonds in light of production operations, stock price trends, and capital market conditions, adhering to relevant legal disclosure obligations [6] Group 7: Future Development Outlook - The company aims to drive growth through a dual strategy of "cast aluminum alloy + recycled deformed aluminum alloy," while leveraging domestic capital market opportunities to enhance product recognition and expand market share [8]

Market Overview - The Shanghai Composite Index is at 3885.23 points, above the annual line, with a change of 0.23% [1] - The total trading volume of A-shares is 1,404.985 billion yuan [1] Stocks Breaking Annual Line - A total of 196 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Debi Group (11.48%) - Lite-On Optoelectronics (10.24%) - Xinlong Health (7.36%) [1] Stock Performance Details - Top performers with deviation rates: - Debi Group: 19.99% increase, latest price 22.51 yuan, deviation rate 11.48% [1] - Lite-On Optoelectronics: 12.94% increase, latest price 25.49 yuan, deviation rate 10.24% [1] - Xinlong Health: 10.06% increase, latest price 7.77 yuan, deviation rate 7.36% [1] - Other notable stocks with smaller deviation rates include: - GQY Vision: 13.54% increase, latest price 7.38 yuan, deviation rate 6.37% [1] - Phoenix Shipping: 6.29% increase, latest price 5.07 yuan, deviation rate 5.66% [1] Additional Stock Insights - Stocks with lower deviation rates that just crossed the annual line include: - Hanxin Technology: 7.99% increase, latest price 42.70 yuan, deviation rate 3.99% [1] - Jinjiang Online: 4.81% increase, latest price 15.92 yuan, deviation rate 3.89% [1] - The overall market shows a mix of strong performers and those just reaching the annual line, indicating varied investor sentiment [1][2]

格隆汇12月12日丨顺博合金(002996.SZ)公布，近日，公司收到部分控股股东及一致行动人暨董事王真 见、王增潮的《关于减持计划实施完成的告知函》，截至本公告披露日，王真见、王增潮以集中竞价交 易方式合计减持公司股份1371.88万股（占公司总股本的2.05%，占剔除公司回购专用证券账户股份后总 股本的2.08%）。本次减持计划已经实施完成，其减持股份总数未超过减持计划约定的股数。 ...

（文章来源：证券日报） 证券日报网讯 12月12日晚间，顺博合金发布公告称，近日，公司收到部分控股股东及一致行动人暨董 事王真见、王增潮的《关于减持计划实施完成的告知函》，截至本公告披露日，王真见、王增潮以集中 竞价交易方式合计减持公司股份13，718，830股（占公司总股本的2.05%，占剔除公司回购专用证券账 户股份后总股本的2.08%）。本次减持计划已经实施完成。 ...

| 证券代码：002996 | 证券简称：顺博合金 | 公告编号：2025-096 | | --- | --- | --- | | 债券代码：127068 | 债券简称：顺博转债 | | 重庆顺博铝合金股份有限公司 关于部分控股股东及一致行动人暨董事减持股份计 划实施完成的公告 股东王增潮、王真见、王启保证向本公司提供的信息内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 占剔除公司回购专用证券账户股份后总股本的2.08%）。本次减持计划已经实 施完成，其减持股份总数未超过减持计划约定的股数。现将具体情况公告如 下： 一、股东减持股份情况 1、股东减持股份情况 | 股东名 称 | 减持方 | 减持期间 | 减持价格 区间（元 | 减持 均价 | 减持股数 | 占总股 本比例 | 占剔除 回购股 份后的 | 减持来 源 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 式 | | /股） | （元/ | （股） | （%） | 总股本 | | | | | | | 股） | | | 比例 | | | | | | | | | | ...

| 证券代码：002996 | 证券简称：顺博合金 | 公告编号：2025-095 | | --- | --- | --- | | 债券代码：127068 | 债券简称：顺博转债 | | 重庆顺博铝合金股份有限公司 关于担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 二、担保调剂情况 为满足全资子公司业务发展及实际经营需要，公司将全资孙公司安 徽渝博铝材有限公司（以下简称"安徽渝博"）未使用的担保额度 5,000 万元调剂给全资子公司顺博合金安徽有限公司（以下简称"安徽顺博"） 使用。公司本次调剂对象均为资产负债率不超过 70%的担保对象，担保 调剂额度在股东会授权范围内，无需再提交公司董事会及股东会审议。 上述担保额度内部调剂完成后,公司为安徽渝博提供的担保额度由 81,200万元调减至76,200万元；公司为安徽顺博提供的担保额度由136， 000 万元调增至 141,000 万元。 三、担保进展情况 近日，公司全资子公司安徽顺博向中国建设银行股份有限公司马鞍 山市分行(以下简称"建设银行马鞍山分行")申请不超过人民币 47,170 万 ...

Group 1 - The company announced an increase in the guarantee limit for the year 2025 from 5 billion to 5.55 billion, totaling 5.55 billion [1] - The company has adjusted 50 million of unused guarantee limits from Anhui Yubo to Anhui Shunbo [1] - The company provided joint liability guarantees for a credit line of 471.7 million from China Construction Bank and 138 million from Industrial Bank [1] Group 2 - As of the announcement date, the total guarantee limit is 5.55 billion, with external guarantee contracts amounting to 4.196 billion, which represents 31.8% of the latest audited net assets of 13.183 billion [1] - The company disclosed financial indicators such as revenue and net profit for its two subsidiaries for the years 2024 and the first nine months of 2025 [1]

Core Viewpoint - The company Shunbo Alloy (002996.SZ), a leader in the recycled aluminum industry, is expanding its production capacity through a private placement to raise up to 585 million yuan for two core projects in the recycled aluminum industry chain [2][3]. Group 1: Fundraising and Expansion Plans - Shunbo Alloy plans to issue up to 100 million shares to no more than 35 specific investors, representing 14.94% of the total share capital as of September 30, 2025, with a fundraising target of no more than 585 million yuan [3]. - The funds raised will be allocated to the construction of the "Annual Production of 630,000 Tons of Low-Carbon Environmentally Friendly Aluminum Alloy Ingot Project" and the "Annual Production of 500,000 Tons of Green Circular High-Performance Aluminum Plate and Strip Project" [5][6]. Group 2: Financial Performance - For the first nine months of 2025, Shunbo Alloy reported a revenue of 11.266 billion yuan, a year-on-year increase of 13.88%, and a net profit attributable to shareholders of 245 million yuan, up 49.12% [9]. - The company's non-recurring net profit increased by 133.71% year-on-year, reflecting improved operational efficiency and cost control, with a reduction in sales and management expenses [9]. Group 3: Industry Position and Growth - Shunbo Alloy has established itself as the largest recycled aluminum producer in Southwest China and a leading player nationally, with a complete aluminum processing industry chain [7][8]. - The company's total assets have grown significantly, reaching 15.257 billion yuan by September 2025, a year-on-year increase of 23.25% [8].

Group 1 - Heng Rui Pharmaceutical has 9 drugs included in the national medical insurance directory for the first time, with an estimated total sales of approximately 8.66 billion yuan for 2024 and 7.55 billion yuan for the first three quarters of 2025 [5] - Junshi Biosciences' products Tuoyi® and Junshida® have been added to the national medical insurance directory, enhancing patient affordability and market promotion [6] - Huadong Medicine's subsidiary has products included in the national medical insurance and commercial insurance innovative drug directories, expected to aid in market promotion [7] Group 2 - Aidi Pharmaceutical's two innovative HIV drugs have successfully renewed their inclusion in the national medical insurance directory, with specific reimbursement prices set [8] - Fuxing Pharmaceutical has multiple products newly included in the national medical insurance directory, which is anticipated to positively impact future performance [9] - Weichuang Biotechnology's product has been included in the national medical insurance directory, which is expected to enhance market promotion and sales [10] Group 3 - Muxi Co., Ltd. announced a final online issuance rate of 0.03348913% after the mechanism was activated, with a total of 22.83 million shares issued [2] - Doushan New Materials reached a consensus on production reduction in the BOPET industry, although the sustainability of long-term price increases remains uncertain [2] - Guanglian Aviation's controlling shareholder has had the detention lifted, allowing normal operations to resume [3] Group 4 - Jiangjian Co., Ltd. clarified that it bears no obligations for any overdue financial products related to its controlling shareholder, confirming normal operations [4] - Tian Ci Materials' controlling shareholder has committed not to reduce holdings, holding 34.35% of the shares [13] - Annie Co., Ltd. is planning a change in control, with stock resuming trading on December 8 [14]